Relationship between body mass index and incidence of breast cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 7, 2015, Pages 11549-11553

  Li, Hai Tao ^a   Han, Xing Hua ^a   Liu, Ying Xin ^a   Leng, Kai Ming ^a   Dong, Guo Min ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Body mass index; Breast cancer; Obesity

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OBESITY; PATHOGENESIS; RETROSPECTIVE STUDY; RISK FACTOR; UNDERWEIGHT; VERY ELDERLY; YOUNG ADULT;

EID: 84940707339     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer 2008; 8: 278.
2. Emaus A, Veierød MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I. Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 2010; 121: 651-660.
3. Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, Weltzien E. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 2008; 19: 1319-1328.
4. Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N. Leptin signaling in breast cancer: an overview. J Cell Biochem 2008; 105: 956-964.
5. Santillán-Benítez JG, Mendieta-Zerón H, Gómez-Oliván LM, Torres-Juárez JJ, González-Bañales JM, Hernández-Peña LV, Ordóñez-Quiroz A. The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA 15-3 are Reliable Biomarkers of Breast Cancer. J Clin Lab Anal 2013; 27: 12-20.
6. Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Fetting J, Davidson NE. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 2012; 118: 5937-5946.
7. Zhou B; Coorperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 2002; 23: 5-10.
8. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 187-193.
9. Hermam S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control 2009; 20: 1397-1408.
10. Tan X, Nelson HH, Langevin SM, McClean M, Marsit CJ, Waterboer T, Pawlita M, Kelsey KT, Michaud DS. Obesity and head and neck cancer risk and survival by human papillomavirus serology. Cancer Causes Control 2015; 26: 111-119.
11. Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer 2008; 8: 278.
12. Group of China Obesity Task Force. [Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents]. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25: 97-102.
13. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354: 270-282.
14. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006; 13: 279-292.
15. Lu MF, Yuan Y Yan SL. Study on Aromatase mRNA Expression in Abdomininal Adipose Tissues of Postmenopausal Women. Tianjin Med J 2004; 610-612.
16. Corbould AM, Judd SJ, Rodgers RJ. Expression of types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J Clin Endocrinol Metab 1998; 83: 187-194.
17. Boonyaratanakornkit V, Pateetin P. The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: molecular mechanisms and therapeutic implications. Biomed Res Int 2015; 2015: 140196.
18. Dowsett M, Folkerd E. Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat 2015; 149: 1-4.
19. Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE; WECARE Study Collaborative Group, Bernstein JL,Bernstein L. Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat 2012; 131: 571-580.
20. Gu JW, Young E, Patterson SG, Makey KL, Wells J, Huang M, Tucker KB, Miele L. Post-menopausal obesity promotes tumor angiogenesis and breast cancer progression in mice. Cancer Biol Ther 2011; 11: 910-917.
21. McKenzie F, Ferrari P, Freisling H, Chajès V, Rinaldi S, de Batlle J, Dahm CC, Overvad K, Baglietto L, Dartois L, Dossus L, Lagiou P, Trichopoulos D, Trichopoulou A, Krogh V, Panico S, Tumino R, Rosso S, Bueno-de-Mesquita HB, May A, Peeters PH, Weiderpass E, Buckland G, Sanchez MJ, Navarro C, Ardanaz E, Andersson A, Sund M, Ericson U, Wirfält E, Key TJ, Travis RC, Gunter M, Riboli E, Vergnaud AC, Romieu I. Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study. Int J Cancer 2015; 136: 2640-8.